Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000116461 | SCV000150389 | uncertain significance | not provided | 2013-08-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002316296 | SCV000849958 | benign | Inborn genetic diseases | 2019-10-26 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001083597 | SCV001007561 | benign | Alpha thalassemia-X-linked intellectual disability syndrome | 2024-01-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000116461 | SCV001883903 | benign | not provided | 2019-08-01 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001083597 | SCV002087301 | benign | Alpha thalassemia-X-linked intellectual disability syndrome | 2020-07-07 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004542838 | SCV004780714 | likely benign | ATRX-related disorder | 2022-05-24 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |